78 related articles for article (PubMed ID: 9152404)
1. An antisense oligonucleotide on the mouse Shaker-like potassium channel Kv1.1 gene prevents antinociception induced by morphine and baclofen.
Galeotti N; Ghelardini C; Papucci L; Capaccioli S; Quattrone A; Bartolini A
J Pharmacol Exp Ther; 1997 May; 281(2):941-9. PubMed ID: 9152404
[TBL] [Abstract][Full Text] [Related]
2. Loss of muscarinic antinociception by antisense inhibition of M(1) receptors.
Ghelardini C; Galeotti N; Bartolini A
Br J Pharmacol; 2000 Apr; 129(8):1633-40. PubMed ID: 10780968
[TBL] [Abstract][Full Text] [Related]
3. Role of potassium channels in the antinociception induced by agonists of alpha2-adrenoceptors.
Galeotti N; Ghelardini C; Vinci MC; Bartolini A
Br J Pharmacol; 1999 Mar; 126(5):1214-20. PubMed ID: 10205011
[TBL] [Abstract][Full Text] [Related]
4. Blockade of clomipramine and amitriptyline analgesia by an antisense oligonucleotide to mKv1.1, a mouse Shaker-like K+ channel.
Galeotti N; Ghelardini C; Capaccioli S; Quattrone A; Nicolin A; Bartolini A
Eur J Pharmacol; 1997 Jul; 330(1):15-25. PubMed ID: 9228410
[TBL] [Abstract][Full Text] [Related]
5. Effect of potassium channel modulators in mouse forced swimming test.
Galeotti N; Ghelardini C; Caldari B; Bartolini A
Br J Pharmacol; 1999 Apr; 126(7):1653-9. PubMed ID: 10323599
[TBL] [Abstract][Full Text] [Related]
6. Acetyl-L-carnitine requires phospholipase C-IP3 pathway activation to induce antinociception.
Galeotti N; Bartolini A; Calvani M; Nicolai R; Ghelardini C
Neuropharmacology; 2004 Aug; 47(2):286-94. PubMed ID: 15223307
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice.
Galeotti N; Quattrone A; Vivoli E; Bartolini A; Ghelardini C
Neuroscience; 2007 Oct; 149(2):409-20. PubMed ID: 17890015
[TBL] [Abstract][Full Text] [Related]
8. Antisense 'knockdowns' of M1 receptors induces transient anterograde amnesia in mice.
Ghelardini C; Galeotti N; Matucci R; Bellucci C; Gualtieri F; Capaccioli S; Quattrone A; Bartolini A
Neuropharmacology; 1999 Mar; 38(3):339-48. PubMed ID: 10219972
[TBL] [Abstract][Full Text] [Related]
9. Antisense knockdown of the Shaker-like Kv1.1 gene abolishes the central stimulatory effects of amphetamines in mice and rats.
Ghelardini C; Quattrone A; Galeotti N; Livi S; Banchelli G; Raimondi L; Pirisino R
Neuropsychopharmacology; 2003 Jun; 28(6):1096-105. PubMed ID: 12700677
[TBL] [Abstract][Full Text] [Related]
10. Messenger RNA and protein expression analysis of voltage-gated potassium channels in the brain of Abeta(25-35)-treated rats.
Pan Y; Xu X; Tong X; Wang X
J Neurosci Res; 2004 Jul; 77(1):94-9. PubMed ID: 15197742
[TBL] [Abstract][Full Text] [Related]
11. Differential modulation by baclofen on antinociception induced by morphine and beta-endorphin administered intracerebroventricularly in the formalin test.
Chung KM; Kim YH; Song DK; Huh SO; Suh HW
Neuropeptides; 1999 Dec; 33(6):534-41. PubMed ID: 10657537
[TBL] [Abstract][Full Text] [Related]
12. Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.
Galeotti N; Quattrone A; Vivoli E; Bartolini A; Ghelardini C
Neuroscience; 2008 May; 153(3):814-22. PubMed ID: 18403125
[TBL] [Abstract][Full Text] [Related]
13. Amitriptyline and clomipramine activate Gi-protein signaling pathway in the induction of analgesia.
Ghelardini C; Galeotti N; Bartolini A
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):1-7. PubMed ID: 11862327
[TBL] [Abstract][Full Text] [Related]
14. The analgesic action of baclofen [beta-(4-chlorophenyl)-gamma-aminobutyric acid].
Levy RA; Proudfit HK
J Pharmacol Exp Ther; 1977 Aug; 202(2):437-45. PubMed ID: 886473
[TBL] [Abstract][Full Text] [Related]
15. Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice.
Shen J; Benedict Gomes A; Gallagher A; Stafford K; Yoburn BC
Synapse; 2000 Dec; 38(3):322-7. PubMed ID: 11020235
[TBL] [Abstract][Full Text] [Related]
16. The role of potassium channels in antihistamine analgesia.
Galeotti N; Ghelardini C; Bartolini A
Neuropharmacology; 1999 Dec; 38(12):1893-901. PubMed ID: 10608284
[TBL] [Abstract][Full Text] [Related]
17. On the mechanism of cross-tolerance between morphine- and nicotine-induced antinociception: involvement of calcium channels.
Biala G; Weglinska B
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):15-21. PubMed ID: 16202496
[TBL] [Abstract][Full Text] [Related]
18. Thyroid hormone regulates expression of shaker-related potassium channel mRNA in rat heart.
Abe A; Yamamoto T; Isome M; Ma M; Yaoita E; Kawasaki K; Kihara I; Aizawa Y
Biochem Biophys Res Commun; 1998 Apr; 245(1):226-30. PubMed ID: 9535813
[TBL] [Abstract][Full Text] [Related]
19. An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance.
Shimoyama N; Shimoyama M; Davis AM; Monaghan DT; Inturrisi CE
J Pharmacol Exp Ther; 2005 Feb; 312(2):834-40. PubMed ID: 15388787
[TBL] [Abstract][Full Text] [Related]
20. Reversible antisense inhibition of Shaker-like Kv1.1 potassium channel expression impairs associative memory in mouse and rat.
Meiri N; Ghelardini C; Tesco G; Galeotti N; Dahl D; Tomsic D; Cavallaro S; Quattrone A; Capaccioli S; Bartolini A; Alkon DL
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4430-4. PubMed ID: 9114006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
